This bill proposes to amend the Arizona Revised Statutes by adding a new chapter that addresses the sale of essential off-patent or generic drugs, specifically targeting price gouging. It defines key terms such as "essential off-patent or generic drug," "price gouging," and "unconscionable increase," while establishing that manufacturers and wholesale distributors are prohibited from engaging in price gouging for these drugs. The bill outlines the conditions under which price increases are permissible and sets forth the responsibilities of manufacturers to provide detailed cost information to the attorney general when notified of significant price increases.

Additionally, the bill grants the attorney general the authority to take legal action against manufacturers or distributors for violations, including seeking court orders to compel compliance, restore funds to consumers, and impose civil penalties. It also ensures that any information shared with the attorney general remains confidential unless waived by the manufacturer or distributor. Overall, the bill aims to protect consumers from excessive pricing of essential medications while maintaining a framework for accountability among drug manufacturers and distributors.